Immuneering News

Immuneering | 4: Statement of changes in beneficial ownership of securities-Director Schall Thomas J.

Jun 13 16:30 ET

Immuneering | 4: Statement of changes in beneficial ownership of securities-Director Feinberg Peter

Jun 13 16:26 ET

Immuneering | 4: Statement of changes in beneficial ownership of securities-Director KEATING LAURIE

Jun 13 16:25 ET

Immuneering | 4: Statement of changes in beneficial ownership of securities-Director CARPENTER ROBERT J

Jun 13 16:24 ET

Immuneering | 4: Statement of changes in beneficial ownership of securities-Director BERMAN ANN E

Jun 13 16:22 ET

Immuneering | 4: Statement of changes in beneficial ownership of securities-Director HAUSMAN DIANA

Jun 13 16:21 ET

Immuneering | 8-K: Current report

Jun 13 16:16 ET

Immuneering | 4: Statement of changes in beneficial ownership of securities-Officer Bookman Michael

May 23 16:25 ET

Immuneering | 4: Statement of changes in beneficial ownership of securities-Officer Brakewood Harold Eugene

May 23 16:23 ET

Immuneering | 4: Statement of changes in beneficial ownership of securities-Officer Neufeld Leah R

May 23 16:22 ET

Immuneering | 4: Statement of changes in beneficial ownership of securities-Officer Morales Mallory

May 23 16:21 ET

Immuneering | 8-K: Current report

May 23 16:17 ET

Immuneering | 8-K: Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates - Reported Positive Topline Results from Phase 1 Portion of its Phase 1/2a Clinical Trial of IMM-1-104 in RAS-Mutant Solid Tumors -

May 7 16:15 ET

Immuneering | 10-Q: Quarterly report

May 7 16:11 ET

Immuneering | DEFA14A: Others

Apr 23 16:21 ET

Immuneering | DEF 14A: Definitive information statements

Apr 23 16:17 ET

Immuneering | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Asset Management, LP(5.81%),Bihua Chen(5.81%), etc.

Apr 15 18:15 ET

Immuneering | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(3.1%)

Apr 10 13:02 ET

Immuneering | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.7%)

Apr 5 12:24 ET

Immuneering | 4: Statement of changes in beneficial ownership of securities-10% Owner Cormorant Asset Management, LP

Apr 3 17:39 ET